BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9438030)

  • 1. Structure-activity of novel rhodacyanine dyes as antitumor agents.
    Kawakami M; Koya K; Ukai T; Tatsuta N; Ikegawa A; Ogawa K; Shishido T; Chen LB
    J Med Chem; 1998 Jan; 41(1):130-42. PubMed ID: 9438030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of novel rhodacyanine dyes that exhibit antitumor activity.
    Kawakami M; Koya K; Ukai T; Tatsuta N; Ikegawa A; Ogawa K; Shishido T; Chen LB
    J Med Chem; 1997 Sep; 40(20):3151-60. PubMed ID: 9379434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo.
    Shi DF; Bradshaw TD; Wrigley S; McCall CJ; Lelieveld P; Fichtner I; Stevens MF
    J Med Chem; 1996 Aug; 39(17):3375-84. PubMed ID: 8765521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and cytotoxic evaluation of substituted sulfonyl-N-hydroxyguanidine derivatives as potential antitumor agents.
    Chern JW; Leu YL; Wang SS; Jou R; Lee CF; Tsou PC; Hsu SC; Liaw YC; Lin HM
    J Med Chem; 1997 Jul; 40(14):2276-86. PubMed ID: 9216847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationships.
    Ohsumi K; Nakagawa R; Fukuda Y; Hatanaka T; Morinaga Y; Nihei Y; Ohishi K; Suga Y; Akiyama Y; Tsuji T
    J Med Chem; 1998 Jul; 41(16):3022-32. PubMed ID: 9685242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
    Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD
    J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity.
    Komatsu Y; Tomizaki KY; Tsukamoto M; Kato T; Nishino N; Sato S; Yamori T; Tsuruo T; Furumai R; Yoshida M; Horinouchi S; Hayashi H
    Cancer Res; 2001 Jun; 61(11):4459-66. PubMed ID: 11389076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11H-Isoquino[4,3-c]cinnolin-12-ones; novel anticancer agents with potent topoisomerase I-targeting activity and cytotoxicity.
    Ruchelman AL; Singh SK; Ray A; Wu X; Yang JM; Zhou N; Liu A; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2004 Feb; 12(4):795-806. PubMed ID: 14759740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer thiopyrano[2,3-d][1,3]thiazol-2-ones with norbornane moiety. Synthesis, cytotoxicity, physico-chemical properties, and computational studies.
    Lesyk R; Zimenkovsky B; Atamanyuk D; Jensen F; Kieć-Kononowicz K; Gzella A
    Bioorg Med Chem; 2006 Aug; 14(15):5230-40. PubMed ID: 16632367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
    Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA
    Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-(beta-Arylvinyl)-3-(beta-arylvinylketo)-1-ethyl-4-piperidinols and related compounds: a novel class of cytotoxic and anticancer agents.
    Dimmock JR; Vashishtha SC; Quail JW; Pugazhenthi U; Zimpel Z; Sudom AM; Allen TM; Kao GY; Balzarini J; De Clercq E
    J Med Chem; 1998 Oct; 41(21):4012-20. PubMed ID: 9767639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, X-ray crystallographic analysis, and antitumor activity of N-(benzothiazole-2-yl)-1-(fluorophenyl)-O,O-dialkyl-alpha-aminophosphonates.
    Jin L; Song B; Zhang G; Xu R; Zhang S; Gao X; Hu D; Yang S
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1537-43. PubMed ID: 16406612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
    Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
    Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 2.
    Tsuzuki Y; Tomita K; Shibamori K; Sato Y; Kashimoto S; Chiba K
    J Med Chem; 2004 Apr; 47(8):2097-109. PubMed ID: 15056007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine and novel derivatives free of positional isomers. Potent inhibitors of cAMP-specific phosphodiesterase and of malignant tumor cell growth.
    Merz KH; Marko D; Regiert T; Reiss G; Frank W; Eisenbrand G
    J Med Chem; 1998 Nov; 41(24):4733-43. PubMed ID: 9822544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.
    Klutchko SR; Hamby JM; Boschelli DH; Wu Z; Kraker AJ; Amar AM; Hartl BG; Shen C; Klohs WD; Steinkampf RW; Driscoll DL; Nelson JM; Elliott WL; Roberts BJ; Stoner CL; Vincent PW; Dykes DJ; Panek RL; Lu GH; Major TC; Dahring TK; Hallak H; Bradford LA; Showalter HD; Doherty AM
    J Med Chem; 1998 Aug; 41(17):3276-92. PubMed ID: 9703473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
    Amishiro N; Okamoto A; Murakata C; Tamaoki T; Okabe M; Saito H
    J Med Chem; 1999 Jul; 42(15):2946-60. PubMed ID: 10425104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of the 7-substituents of 5,4'-diamino-6,8,3'-trifluoroflavone, a potent antitumor agent.
    Akama T; Ishida H; Kimura U; Gomi K; Saito H
    J Med Chem; 1998 Jun; 41(12):2056-67. PubMed ID: 9622547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 2,8-disubstituted imidazo[1,5-a]pyrimidines with potent antitumor activity.
    Matsumoto H; Ikeda K; Nagata N; Takayanagi H; Mizuno Y; Tanaka M; Sasaki T
    J Med Chem; 1999 May; 42(9):1661-6. PubMed ID: 10229634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.